688046: GemPharmatech Co., Ltd. - Summary | Jitta

GemPharmatech Co., Ltd.

CHN:688046

Price
CN¥20.60
Loss Chance
47.5%
5.80JITTA SCORE
138.35%Over Jitta Line
Jitta Ranking
66 / 487
685 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (65)
Recent Business Performance (98)
Financial Strength (82)
Return to Shareholders (16)
Competitive Advantage (52)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Key Stats
Jitta Score
Jitta Line
5.80
138.35%
4.24
> 1,000%
Life Sciences Tools and Services
4.75
> 1,000%
6.36
40.42%
5.29
> 1,000%
COMPANY DESCRIPTION
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.